Comments
Drug firm Ipca Laboratories on Tuesday posted a 52 per cent jump in its net profit at Rs 160.18 crore for the third quarter ended December 31, 2018.
The company had posted a net profit of Rs 105.58 crore for the same period of previous fiscal. Total income of the company grew 10 per cent to Rs 960.22 crore during the quarter under review as against Rs 870.18 crore in the same period of the previous fiscal, Ipca Laboratories said in a regulatory filing. Shares of the company were trading at Rs 736 apiece on BSE, up 0.82 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.